Brief: Bionano Announces Publication Of Interim Readout From Second Phase Of Clinical Trial Analyzing Optical Genome Mapping As Standard Of Care (Soc) For Prenatal Testing
Jan 24 (Reuters) - Bionano Genomics Inc BNGO.O :
* BIONANO ANNOUNCES PUBLICATION OF INTERIM READOUT FROM
SECOND
PHASE OF CLINICAL TRIAL ANALYZING OPTICAL GENOME MAPPING AS
STANDARD OF CARE (SOC) FOR PRENATAL TESTING
Source text for Eikon: ID:nGNX4ZhnzK
Further company coverage: BNGO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bionano Genomics
See all newsBionano Genomics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Bionano Genomics Q2 revenue rises on increased clinical adoption
Brief: Bionano Genomics Q2 Revenue USD 8.2 Million
Bionano Genomics, Inc. expected to post a loss of 68 cents a share - Earnings Preview
Bionano Genomics Q1 revenue up 4%, margin improves; to retire convertible debt